Waldencast PLC (WALD) Actualités

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare...

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates

LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand...

Waldencast Announces Participation in the 2025 IMCAS World Congress

LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand...

Milk Makeup to Launch at Ulta Beauty This Spring

Milk Makeup to Launch at Ulta Beauty This Spring PR Newswire NEW YORK, Jan. 28, 2025 The New York City based...

Waldencast Announces Participation in the ICR Conference 2025

WHITE PLAINS, N.Y., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the...

Waldencast Reports Q3 2024 Financial Results

$70.2 million of Net Revenue Q3 2024+34.6% Comparable Net Revenue GrowthBoth brands accelerating from Q2...

Waldencast plc Announces Third Quarter Fiscal 2024 Results Conference Call and Webcast

LONDON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand...

Waldencast plc Announces Board Appointments and Annual General Meeting

NEW YORK, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a...

Obagi Medical Announces the Launch of ELASTIDERM® Lift Up & Sculpt Facial Moisturizer and ELASTIDERM® Advanced Filler Concentrate

  NEW YORK, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare...

Form 144 - Report of proposed sale of securities

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Waldencast Reports Q2 2024 Financial Results

$63.3 million of Net Revenue Q2 2024 +25.7% net revenue Comparable Growth: +30.9% Obagi Medical and +20.0% Milk...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]